Breast implant-associated anaplastic large cell lymphoma: two distinct clinicopathological variants with different outcomes

per Laurent, C., Delas, A., Gaulard, P., Haioun, C., Moreau, A., Xerri, L., Traverse-Glehen, A., Rousset, T., Quintin-Roue, I., Petrella, T., Emile, J. F., Amara, N., Rochaix, P., Chenard-Neu, M. P., Tasei, A. M., Menet, E., Chomarat, H., Costes, V., Andrac-Meyer, L., Michiels, J. F., Chassagne-Clement, C., de Leval, L., Brousset, P., Delsol, G., Lamant, L.
Publicat a Ann Oncol (2016)

Immune checkpoint inhibitor treatment of a first cancer is associated with a decreased incidence of second primary cancer

per Heudel, P., Chabaud, S., Perol, D., Flechon, A., Fayette, J., Combemale, P., Tredan, O., Desseigne, F., de la Fouchardiere, C., Boyle, H., Perol, M., Bachelot, T., Cassier, P., Avrillon, V., Terret, C., Michallet, A.-S., Neidhardt-Berard, E.-M., Nicolas-Virelizier, E., Dufresne, A., Belhabri, A., Brahmi, M., Lebras, L., Nicolini, F., Sarabi, M., Rey, P., Bonneville-Levard, A., Rochefort, P., Provensal, A.-M., Eberst, L., Assaad, S., Swalduz, A., Saintigny, P., Toussaint, P., Guillermin, Y., Castets, M., Coutzac, C., Meeus, P., Dupré, A., Durand, T., Crochet, H., Fervers, B., Gomez, F., Rivoire, M., Gregoire, V., Claude, L., Chassagne-Clement, C., Pilleul, F., Mognetti, T., Russias, B., Soubirou, J.-L., Lasset, C., Chvetzoff, G., Mehlen, P., Beaupère, S., Zrounba, P., Ray-Coquard, I., Blay, J.-Y.
Publicat a ESMO Open (2021)